ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
60 hedge funds and large institutions have $136M invested in ChemoCentryx, Inc. in 2013 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 22 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
16% more capital invested
Capital invested by funds: $117M → $136M (+$19M)
9% less funds holding
Funds holding: 66 → 60 (-6)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
83% less call options, than puts
Call options by funds: $36K | Put options by funds: $214K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$12.5M |
| 2 |
BC
Broadfin Capital
New York
|
+$5.33M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$5.16M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.66M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$16.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.95M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.81M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.78M |
CCXI Hedge Fund Activity: Q4 2013 in Review
60 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2013, worth a combined $136M — up 16% from $117M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of CCXI and 16 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 19 added.
The largest buyer was BVF Inc, adding an estimated $12.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $16.9M sold.
- 60 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2013, down from 66 in Q3 2013.
- Funds reported $136M of ChemoCentryx, Inc. stock for Q4 2013, up 16% quarter-over-quarter.
- 16 funds opened new ChemoCentryx, Inc. positions in Q4 2013 and 22 closed out, a net change of -6 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2013 was BVF Inc, an estimated $12.5M added.
- The largest ChemoCentryx, Inc. seller in Q4 2013 was RA Capital Management, an estimated $16.9M sold.
Based on aggregated 13F filings for Q4 2013.